EXSCIENTIA PLC's ticker is and the CUSIP is 30223G102. A total of 78 filers reported holding EXSCIENTIA PLC in Q2 2024. The put-call ratio across all filers is 7.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1 | – | 230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 13,086,600 | $258,591,000 | 12.24% |
| Bill & Melinda Gates Foundation | 1,590,909 | $31,400,000 | 9.53% |
| Pivotal bioVenture Partners Investment Advisor LLC | 772,285 | $15,260,000 | 6.38% |
| Triatomic Management LP | 455,984 | $9,010,000 | 5.52% |
| Nan Fung Group Holdings Ltd | 770,200 | $15,219,000 | 4.50% |
| SB Global Advisers Ltd | 5,681,818 | $112,273,000 | 2.23% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,648,154 | $32,568,000 | 0.91% |
| SECTORAL ASSET MANAGEMENT INC | 301,433 | $5,956,000 | 0.90% |
| Laurion Capital Management LP | 2,132,154 | $42,131,000 | 0.43% |
| Casdin Capital, LLC | 713,900 | $14,107,000 | 0.40% |